CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 116 enrolled
Drug / intervention
Chlorhexidine gluconate oral rinse +2 moredrug
Likely dose
Chlorhexidine gluconate oral rinse 15 mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04830969
NCT04830969Phase 2Completed

Impact of Periodontal Therapy on Patients With Diabetes: A Pilot Study

State University of New York at Buffalo·interventional·Posted Apr 5, 2021·Updated Mar 1, 2023

In Brief

A Phase 2 clinical trial evaluating Chlorhexidine gluconate oral rinse, Scaling & Root Planing, and 1 other intervention for Diabetes Mellitus, Type II and Periodontitis. Completed, enrolled 116 participants across 1 site.

Detailed Summary

With poorly controlled diabetes, periodontal status often worsens, and with severe periodontal conditions there is often poorer glycemic control. There are few published reports investigating the efficacy of periodontal therapy in diabetics and fewer that include evaluation of the oral microbial profiles (the microbiome). The investigators will examine systemic changes in diabetes status and microbiome influences on clinical response to periodontal therapy in a randomized clinical trial of participants with and without diabetes and with periodontal disease. Two different treatments will be used: 1. Scaling and root planning (SRP) alone, or 2. SRP and supportive periodontal therapy (SPT), the use of chlorhexidine gluconate rinse (Paroex®) and a rubber interdental bristle cleaner (Soft-Picks) The main goal of this clinical trial is to evaluate the effects of SRP alone versus SRP+SPT on clinical, microbiological and immunological status in participants. A clearer understanding of how periodontal therapy affects diabetes status could lead to the development of new therapies for periodontal disease and diabetes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsSunstar, Inc.

Timeline

Phase 2CompletedFinished
2017201820192020202120222023202420252026
First PostedApr 5, 2021
Enrollment StartNov 8, 2016
Primary CompletionJan 28, 2021
TodayJul 2, 2026
Enrollment to primary: 4.2 yearsPosted 5.2 years ago

Interventions

Chlorhexidine gluconate oral rinsedrug

Paroex® is a non-alcohol chlorhexidine preparation. Participants are to use 15 mL morning and evening for 3 months. With use of chlorhexidine, there is risk of reversible staining of teeth and the possibility of some alteration in taste. There is increased likeliness of staining in smokers, coffee drinkers and those who are susceptible to teeth staining in general. The cleaning of the front teeth is provided at the 3-month visit and helps to reduce any staining that may occur. If there is any alteration in taste, it should go away when use of chlorhexidine stops.

Scaling & Root Planingprocedure

SRP is standard treatment of periodontitis. It involves using a scaler to remover subgingival plaque and other debris in the space between teeth and gums.

Soft Picksdevice

Soft Picks are a rubber interdental bristle cleaner. Participants are to use Soft Picks morning and evening for all 12 months of the study. They may cause some bleeding of the gums at first usage, but the bleeding should lessen and stop as use is continued (as gums heal). Soft-Picks are a readily available consumer product sold in supermarkets and drug stores.